{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:41:02Z","timestamp":1793691662839,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJS2123"],"award-info":[{"award-number":["JPMJS2123"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23\\u202FK06135"],"award-info":[{"award-number":["23\\u202FK06135"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22\\u202FK06131"],"award-info":[{"award-number":["22\\u202FK06131"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ1943"],"award-info":[{"award-number":["24KJ1943"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116969","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:21:11Z","timestamp":1781454071000},"page":"116969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Methotrexate inhibits the TEL-JAK2\u2013STAT pathway through a folate metabolism-dependent mechanism in Ba\/F3 cells"],"prefix":"10.1016","volume":"185","author":[{"given":"Masaya","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Funakoshi-Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116969_bb0005","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate: an old drug with new tricks","volume":"20","author":"Bedoui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116969_bb0010","first-page":"527","article-title":"Applications cliniques, limites et perspectives des analyses pharmacog\u00e9n\u00e9tiques et pharmacocin\u00e9tiques des traitements anticanc\u00e9reux","volume":"72","author":"Chantry","year":"2014","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"10.1016\/j.intimp.2026.116969_bb0015","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/molecules24061140","article-title":"DHFR inhibitors: reading the past for discovering novel anticancer agents","volume":"24","author":"Raimondi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116969_bb0020","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/ja035272r","article-title":"How dihydrofolate reductase facilitates protonation of dihydrofolate","volume":"125","author":"Rod","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.intimp.2026.116969_bb0025","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41586-022-05168-0","article-title":"Methotrexate recognition by the human reduced folate carrier SLC19A1","volume":"609","author":"Wright","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116969_bb0030","first-page":"2036","article-title":"Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid","volume":"48","author":"Lorico","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116969_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1254\/jphs.FP0050761","article-title":"Cell-cycle-dependent pharmacology of methotrexate in HL-60","volume":"99","author":"Yamauchi","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.116969_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41392-024-01934-w","article-title":"The JAK-STAT pathway: from structural biology to cytokine engineering","volume":"9","author":"Lv","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116969_bb0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1534-5807(02)00376-3","article-title":"The jak\/STAT pathway in model organisms: emerging roles in cell movement","volume":"3","author":"Hou","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","article-title":"Jaks and Stats in signaling by the cytokine receptor superfamily","volume":"11","author":"Ihle","year":"1995","journal-title":"Trends Genet."},{"key":"10.1016\/j.intimp.2026.116969_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0060","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1073\/pnas.93.16.8324","article-title":"Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5","volume":"93","author":"Klingm\u00fcller","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116969_bb0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116969_bb0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0092-8674(94)90357-3","article-title":"Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions","volume":"76","author":"Shuai","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7871432","article-title":"Contribution of STAT SH2 groups to specific interferon signaling by the jak-STAT pathway","volume":"267","author":"Heim","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116969_bb0080","article-title":"Regulatory mechanisms of STAT3 in GBM and its impact on TMZ resistance","volume":"17","author":"Lv","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116969_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2174\/0109298665398122250929045705","article-title":"PLEKHG7 expression: a biomarker for prognosis and targeted therapy in diffuse large B cell lymphoma","volume":"32","author":"Lyu","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.intimp.2026.116969_bb0090","article-title":"Protective effect of Platycodin D on allergic rhinitis in mice through DPP4\/JAK2\/STAT3 pathway inhibition","volume":"17","author":"Jia","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116969_bb0095","article-title":"Mitochondria-targeted uncouplers decrease inflammatory reactions in endothelial cells by enhancing methylation of the ICAM1 gene promoter","volume":"17","author":"Zinovkina","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116969_bb0100","article-title":"Ergothioneine suppresses amyloid \u03b2-induced tau phosphorylation and cytotoxicity by inactivating glycogen synthase kinase-3\u03b2 in cultured neurons","volume":"17","author":"Shibagaki","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116969_bb0105","article-title":"Physalin B reduces tau phosphorylation and cell apoptosis in HEK293 cells by activating FoxO1","volume":"17","author":"Zhang","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116969_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003022","article-title":"Ab initio modeling and experimental assessment of Janus kinase 2 (JAK2) kinase-pseudokinase complex structure","volume":"9","author":"Wan","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.intimp.2026.116969_bb0125","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1074\/jbc.M109.040733","article-title":"STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant","volume":"285","author":"Funakoshi-Tago","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116969_bb0130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116969_bb0135","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116969_bb0140","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116969_bb0145","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood.V95.12.3891","article-title":"TEL-JAK2 transgenic mice develop T-cell leukemia","volume":"95","author":"Carron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116969_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130078","article-title":"Methotrexate is a JAK\/STAT pathway inhibitor","volume":"10","author":"Thomas","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.116969_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/0113892029280454240214072212","article-title":"Effect of calebin-a on critical genes related to NAFLD: a protein\u2013protein interaction network and molecular docking study","volume":"25","author":"Mahmoudi","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.intimp.2026.116969_bb0160","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.bcp.2008.09.012","article-title":"Licochalcone a is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation","volume":"76","author":"Funakoshi-Tago","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116969_bb0165","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.3390\/ijms25073693","article-title":"FL118 is a potent therapeutic agent against chronic myeloid leukemia resistant to BCR-ABL inhibitors through targeting RNA helicase DDX5","volume":"25","author":"Takeda","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116969_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112248","article-title":"DDX5 is required for JAK2V617F-induced cell proliferation and tumorigenesis independent of its RNA helicase activity","volume":"138","author":"Takeda","year":"2026","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.116969_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110985","article-title":"The acetylation of STAT3 at K685 attenuates NPM-ALK-induced tumorigenesis","volume":"114","author":"Korai","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.116969_bb0180","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","article-title":"Bcr\/Abl activates transcription of the Bcl-X gene through STAT5","volume":"96","author":"Gesbert","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116969_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0190","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/me.2015-1170","article-title":"Heregulin co-opts PR transcriptional action via Stat3 role as a coregulator to drive cancer growth","volume":"29","author":"Proietti","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.intimp.2026.116969_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","article-title":"The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia","volume":"92","author":"Przanowski","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116969_bb0200","series-title":"Folinic Acid. In: StatPearls","author":"Gristan","year":"2024"},{"key":"10.1016\/j.intimp.2026.116969_bb0205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116969_bb0210","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1073\/pnas.69.7.1855","article-title":"5-Fluoro-2\u2032-deoxyuridylate: covalent complex with thymidylate synthetase","volume":"69","author":"Santi","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116969_bb0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/bi00700a012","article-title":"Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate","volume":"13","author":"Santi","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2026.116969_bb0220","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116969_bb0225","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.3324\/haematol.2017.165738","article-title":"Low-dose methotrexate in myeloproliferative neoplasm models","volume":"102","author":"Chinnaiya","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2026.116969_bb0230","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/bjh.16193","article-title":"Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms","volume":"187","author":"Francis","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2026.116969_bb0235","article-title":"Pediatric primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with unusually long clinical course","author":"Meng","year":"2025","journal-title":"J. Cutan. Pathol. (advance online publication)"},{"key":"10.1016\/j.intimp.2026.116969_bb0240","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/s41467-018-07188-9","article-title":"The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116969_bb0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s42003-024-06290-7","article-title":"PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth","volume":"7","author":"Abe","year":"2024","journal-title":"Communications Biology"},{"key":"10.1016\/j.intimp.2026.116969_bb0250","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1039\/D2NP00086E","article-title":"S-adenosylmethionine: more than just a methyl donor","volume":"40","author":"Lee","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.intimp.2026.116969_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2010.12.020","article-title":"JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation","volume":"19","author":"Liu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116969_bb0260","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.freeradbiomed.2011.12.025","article-title":"Identification of a redox-sensitive switch within the JAK2 catalytic domain","volume":"52","author":"Smith","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116969_bb0265","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10495-005-2947-z","article-title":"Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production","volume":"10","author":"Huang","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2026.116969_bb0270","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.exphem.2016.08.005","article-title":"Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56\u03b1 subunit","volume":"44","author":"Kawashima","year":"2016","journal-title":"Exp. Hematol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:44:42Z","timestamp":1784231082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S1567576926008155"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116969","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate inhibits the TEL-JAK2\u2013STAT pathway through a folate metabolism-dependent mechanism in Ba\/F3 cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116969"}}